Literature DB >> 20230400

Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus.

Joseph M Flynn1, Leslie Andritsos, David Lucas, John C Byrd.   

Abstract

Second primary malignancies have long been associated with chronic lymphocytic leukaemia (CLL). We assessed secondary tumour samples from CLL and control patients for the presence of human papilloma virus (HPV). 132 CLL patients with 44 second malignancies were compared to a matched randomly-identified control population of 264 non-CLL patients with 54 solid malignancies. Polymerase chain reaction was performed with the highly conserved MY09/MY11 HPV primer. None of control samples were HPV-positive, while 53% of samples from the CLL group were positive. This report describes preliminary evidence for the presence of HPV in secondary malignancies, in patients with CLL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230400      PMCID: PMC4038061          DOI: 10.1111/j.1365-2141.2010.08110.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation.

Authors:  S Euvrard; J Kanitakis; C Pouteil-Noble; G Dureau; J L Touraine; M Faure; A Claudy; J Thivolet
Journal:  J Am Acad Dermatol       Date:  1995-08       Impact factor: 11.527

2.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 3.  The genetic program of genital human papillomaviruses in infection and cancer.

Authors:  L P Turek; E M Smith
Journal:  Obstet Gynecol Clin North Am       Date:  1996-12       Impact factor: 2.844

4.  Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.

Authors:  C A Harwood; T Surentheran; J M McGregor; P J Spink; I M Leigh; J Breuer; C M Proby
Journal:  J Med Virol       Date:  2000-07       Impact factor: 2.327

5.  Cancer after kidney transplantation in the United States.

Authors:  Bertram L Kasiske; Jon J Snyder; David T Gilbertson; Changchun Wang
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

6.  Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients.

Authors:  L M Tieben; R J Berkhout; H L Smits; J N Bouwes Bavinck; B J Vermeer; J A Bruijn; F J Van der Woude; J Ter Schegget
Journal:  Br J Dermatol       Date:  1994-08       Impact factor: 9.302

7.  Malignancy after kidney transplantation: results of 400 patients from a single center.

Authors:  Piero Stratta; Veronica Morellini; Claudio Musetti; Ernesto Turello; Daniela Palmieri; Elisa Lazzarich; Tiziana Cena; Corrado Magnani
Journal:  Clin Transplant       Date:  2008-02-27       Impact factor: 2.863

8.  Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.

Authors:  Mouhammed J Kyasa; Linda Hazlett; Rudolph S Parrish; Steven A Schichman; Clive S Zent
Journal:  Leuk Lymphoma       Date:  2004-03

9.  Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.

Authors:  L A Stark; M J Arends; K M McLaren; E C Benton; H Shahidullah; J A Hunter; C C Bird
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

10.  Primary malignant neoplasms associated with chronic lymphocytic leukemia.

Authors:  A Santoro; F Rilke; F Franchi; S Monfardini
Journal:  Tumori       Date:  1980-08-31
View more
  7 in total

1.  Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.

Authors:  Charles C Chu; Lu Zhang; Arjun Dhayalan; Briana M Agagnina; Amanda R Magli; Gia Fraher; Sebastien Didier; Linda P Johnson; William J Kennedy; Rajendra N Damle; Xiao-Jie Yan; Piers E M Patten; Saul Teichberg; Prasad Koduru; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

2.  Small lymphocytic lymphoma obscuring microscopic tonsillar squamous cell carcinoma: an unknown occurrence with a known primary.

Authors:  Eugen C Minca; Saurin R Popat; Manpreet K Chadha; Mihai Merzianu
Journal:  Head Neck Pathol       Date:  2010-12-01

Review 3.  Impact of exercise on the immune system and outcomes in hematologic malignancies.

Authors:  Andrea Sitlinger; Danielle M Brander; David B Bartlett
Journal:  Blood Adv       Date:  2020-04-28

Review 4.  Chronic lymphocytic leukaemia.

Authors:  Thomas J Kipps; Freda K Stevenson; Catherine J Wu; Carlo M Croce; Graham Packham; William G Wierda; Susan O'Brien; John Gribben; Kanti Rai
Journal:  Nat Rev Dis Primers       Date:  2017-01-19       Impact factor: 52.329

Review 5.  Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature.

Authors:  J Zampella; B Cohen
Journal:  Skin Health Dis       Date:  2022-02-09

6.  The Human Bone Marrow Is Host to the DNAs of Several Viruses.

Authors:  Mari Toppinen; Antti Sajantila; Diogo Pratas; Klaus Hedman; Maria F Perdomo
Journal:  Front Cell Infect Microbiol       Date:  2021-04-22       Impact factor: 5.293

Review 7.  Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.

Authors:  Silvia Sánchez-Ramón; Fatima Dhalla; Helen Chapel
Journal:  Front Immunol       Date:  2016-08-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.